Array Technologies, Inc. Reports Financial Results for the Third Quarter 2022 – Delivers record revenue of $515 million and the fourth consecutive quarter of gross margin improvement
Go back to Array Technologies, Inc. Reports Financial Results for the Third Quarter 2022 – Delivers record revenue of $515 million and the fourth consecutive quarter of gross margin improvement| Array Biopharma, Inc. (NASDAQ: ARRY) | Delayed: 8.47 +0.47 (5.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.00 | 52 Week High | $7.27 | |||
| Open | $7.91 | 52 Week Low | $2.39 | |||
| Day High | $8.69 | P/E | N/A | |||
| Day Low | $7.91 | EPS | $-0.61 | |||
| Volume | 2,578,982 | |||||
